1. Home
  2. LXRX vs OFIX Comparison

LXRX vs OFIX Comparison

Compare LXRX & OFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • OFIX
  • Stock Information
  • Founded
  • LXRX 1995
  • OFIX 1987
  • Country
  • LXRX United States
  • OFIX United States
  • Employees
  • LXRX 103
  • OFIX N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • OFIX Medical/Dental Instruments
  • Sector
  • LXRX Health Care
  • OFIX Health Care
  • Exchange
  • LXRX Nasdaq
  • OFIX Nasdaq
  • Market Cap
  • LXRX 388.6M
  • OFIX 440.0M
  • IPO Year
  • LXRX 2000
  • OFIX N/A
  • Fundamental
  • Price
  • LXRX $1.07
  • OFIX $10.77
  • Analyst Decision
  • LXRX Buy
  • OFIX Strong Buy
  • Analyst Count
  • LXRX 4
  • OFIX 5
  • Target Price
  • LXRX $3.67
  • OFIX $21.50
  • AVG Volume (30 Days)
  • LXRX 3.5M
  • OFIX 287.6K
  • Earning Date
  • LXRX 08-06-2025
  • OFIX 08-05-2025
  • Dividend Yield
  • LXRX N/A
  • OFIX N/A
  • EPS Growth
  • LXRX N/A
  • OFIX N/A
  • EPS
  • LXRX N/A
  • OFIX N/A
  • Revenue
  • LXRX $31,213,000.00
  • OFIX $804,529,000.00
  • Revenue This Year
  • LXRX N/A
  • OFIX $3.70
  • Revenue Next Year
  • LXRX N/A
  • OFIX $5.13
  • P/E Ratio
  • LXRX N/A
  • OFIX N/A
  • Revenue Growth
  • LXRX 1251.21
  • OFIX 5.85
  • 52 Week Low
  • LXRX $0.28
  • OFIX $10.24
  • 52 Week High
  • LXRX $2.25
  • OFIX $20.73
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 52.30
  • OFIX 43.09
  • Support Level
  • LXRX $1.00
  • OFIX $11.09
  • Resistance Level
  • LXRX $1.11
  • OFIX $11.74
  • Average True Range (ATR)
  • LXRX 0.10
  • OFIX 0.38
  • MACD
  • LXRX -0.03
  • OFIX 0.01
  • Stochastic Oscillator
  • LXRX 16.28
  • OFIX 19.17

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

About OFIX Orthofix Medical Inc. (DE)

Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries across the globe. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.

Share on Social Networks: